Left ventricular systolic asynchrony: an important sign for cardiac involvement in plaque-type psoriasis
Cihan Örem1, Zeynep Kazaz, Savaş Yaylı
1Department of Cardiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Insights
Psoriasis patients exhibit increased left ventricular (LV) asynchrony, a novel cardiac finding. This LV asynchrony is linked to elevated inflammatory markers and may indicate subclinical cardiac involvement in psoriasis.
Area of Science:
- Cardiology
- Dermatology
- Inflammation
Background:
- Psoriasis is a chronic inflammatory disease.
- Psoriasis is independently associated with cardiovascular diseases (CVD).
- Subclinical cardiac involvement in psoriasis requires further investigation.
Purpose of the Study:
- To evaluate the relationship between left ventricular (LV) asynchrony and psoriasis.
- To assess cardiac function in psoriasis patients without diagnosed CVD.
- To identify potential cardiac manifestations in early-stage psoriasis.
Main Methods:
- Tissue Synchronization Imaging (TSI) and echocardiography were used to assess LV asynchrony.
- 31 psoriasis patients and 25 healthy controls were included.
- Inflammatory markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were measured.
Main Results:
- Psoriasis patients showed significantly increased LV asynchrony compared to controls.
- LV asynchrony was present in 67.7% of psoriasis patients.
- Higher CRP and ESR levels were observed in psoriatic patients with LV asynchrony.
Conclusions:
- LV asynchrony is a novel finding in patients with psoriasis.
- LV asynchrony may represent an early indicator of cardiac involvement in psoriasis.
- The study highlights the link between psoriasis, inflammation, and subclinical cardiac dysfunction.
Abstract:
Psoriasis is associated with cardiovascular diseases (CVD). The purpose of this study was to evaluate the relationship between Left Ventricular (LV) asynchrony and psoriasis. Asynchrony was assessed in 31 patients with psoriasis without evidence of CVD and 25 healthy subjects. All the patients and controls were subjected to tissue synchronization imaging (TSI), and conventional and tissue Doppler echocardiography. The time to regional peak systolic tissue velocity (Ts) in LV by the six-basal-six-midsegmental model was measured on ejection phase TSI images, and four TSI parameters of systolic asynchrony were computed. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) levels in psoriatic patients were measured. All TSI parameters of LV asynchrony increased in psoriatic patients compared to the controls: the standard deviation (SD) of the 12 LV segments Ts (37.3 ± 14.8 vs. 24.6 ± 11.1, P = 0.002); the maximal difference in Ts between any two of the 12 LV segments (112.7 ± 39.8 vs. 83.1 ± 38.1, P = 0.01), the SD of the six basal LV segments (36.2 ± 17.3 vs. 23.2 ± 14.5, P = 0.008); and the maximal difference in Ts between any two of the six basal LV segments (91.3 ± 43.5 vs. 60.5 ± 37.3, P = 0.01). LV asynchrony was observed in 67.7% of psoriatic patients. Higher CRP (1.9 ± 1.3 vs. 0.92 ± 1.4, P = 0.04) and ESR (34.8 ± 17.3 vs. 20 ± 15.3, P = 0.03) levels were determined in patients with LV asynchrony. Regression analysis showed LV systolic asynchrony (P = 0.02), Tei index (P = 0.03), EF (P = 0.04), and E/A ratio (P = 0.04) were independently associated with psoriasis. LV asynchrony firstly described in patients with psoriasis may be an important finding of cardiac involvement in psoriasis.
More Related Videos
08:34Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis I: Introduction
Cardiovascular System Abnormal Findings II: Auscultation
Abnormal Heart Sounds
Gallops:
Rheumatic Heart Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Valve Prolapse I: Introduction
